← Insider buys
MCRB

Seres Therapeutics, Inc. · Healthcare

President and CEO Roger Pomerantz sold $3.7M of Seres Therapeutics, Inc.

Sold$3,693,795
$27.20Price
135,788Shares
−86%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Fri, Apr 1. Filed Tue, Apr 5, 8:59 PM ET, after the close. Not investment advice.